Ikeda I, Inoue O, Kurata K
J Nucl Med. 1977 Dec;18(12):1222-9.
The organ distributions of four different Tc-99m dimercaptosuccinate complexes ("Tc-DMS", Complexes 1 to 4) were determined using mice and were evaluated as renal imaging agents. The highest kidney uptake was observed with Complex 2:21.7% of dose, 3 hr after injection. The biologic distributions and gel chromatographic analyses using carrier Tc-99 and Sn-113 indicate that there is little possibility of mixed metal complexes of the type Tc-Sn-DMS: rather they contain only Tc + DMS. The labeling procedure for Tc-99m DMS as a renal agent proceeds in two steps: a rapid formation of Complex 1, and a slower, rate-determining step from Complex 1 to Complex 2. A reproducible lyophilized kit has been prepared. The yield of complex 2 greatly depends on the reconstitution volume of 99mTcO4-; yield averages 89% using 2 ml of 99mTcO4-eluate.
使用小鼠确定了四种不同的锝-99m二巯基丁二酸配合物(“Tc-DMS”,配合物1至4)的器官分布,并将其作为肾显像剂进行评估。配合物2在注射后3小时观察到最高的肾脏摄取量:占给药剂量的21.7%。使用载体锝-99和锡-113进行的生物分布和凝胶色谱分析表明,几乎不存在Tc-Sn-DMS类型的混合金属配合物:相反,它们仅包含Tc + DMS。作为肾显像剂的锝-99m DMS的标记过程分两步进行:快速形成配合物1,以及从配合物1到配合物2的较慢的速率决定步骤。已经制备了可重现的冻干试剂盒。配合物2的产率很大程度上取决于99mTcO4-的复溶体积;使用2 ml的99mTcO4洗脱液时产率平均为89%。